Remove Cholesterol Remove Kidney Disease Remove Peripheral Arterial Disease
article thumbnail

New Guidelines on Peripheral Artery Disease Issued by American Heart Association, American College of Cardiology and Leading Medical Societies

DAIC

A new joint guideline from the American Heart Association (AHA), the American College of Cardiology (ACC) and nine other medical societies reports early diagnosis and treatment of peripheral artery disease is essential to improve outcomes and reduce amputation risk, heart attack, stroke and death for people with Peripheral Artery Disease (PAD).

article thumbnail

2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association

Circulation

METHODS:The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing.

article thumbnail

Physiology Friday #196: Resistance Training and Heart Health

Physiologically Speaking

Specifically: - HDL cholesterol increases by 2–12 mg/dL - Total cholesterol decreases by 8 mg/dL - Triglycerides decrease by 7–13 mg/dL - LDL cholesterol may decrease by 10–13 mg/dL in adults at high cardiometabolic risk Weight and body composition Here’s where resistance exercise shines.

article thumbnail

Physiology Friday #196: Resistance Training and Heart Health

Physiologically Speaking

Specifically: - HDL cholesterol increases by 2–12 mg/dL - Total cholesterol decreases by 8 mg/dL - Triglycerides decrease by 7–13 mg/dL - LDL cholesterol may decrease by 10–13 mg/dL in adults at high cardiometabolic risk Weight and body composition Here’s where resistance exercise shines.

article thumbnail

Lowering Atherosclerotic Cardiovascular Disease Events by Treating Residual Inflammatory Risk

DAIC

Inflammation driven by signaling cytokines, circulating immune cells, adhesion molecules, and oxidized low-density lipoprotein cholesterol (LDL-C) leads to atherosclerotic plaque development, plaque progression, and eventual rupture.14,15 Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. μ/L on 0.6 N Engl J Med.